Chronic inflammation and oxidative stress play significant roles in the development of various diseases like diabetes, cancer, and cardiovascular diseases. This study aimed to explore the po-tential therapeutic benefits of Annona crassiflora (Araticum-do-Cerrado) leaves, specifically fo-cusing on their anti-inflammatory, antioxidant, and anti-glycation properties. To achieve this, a hydroethanolic extract of the plant’s leaves (EHAC) was prepared and subjected to phytochemical analysis and in vitro tests to evaluate its effects. The tests included assessing its impact on fibro-blast cytotoxicity, anti-inflammatory capabilities (phagocytosis and macrophage spreading), an-tioxidant activity (DPPH and lipid peroxidation), and anti-glycation activity. The results indicated that EHAC contains high levels of phenolic compounds, including rutin and quercetin. The ex-tract demonstrated strong anti-inflammatory activity by significantly inhibiting phagocytosis and macrophage spreading. Furthermore, it exhibited high antioxidant capacity by inhibiting lipid peroxidation and scavenging free radicals. Additionally, it showed notable anti-glycation activity by completely inhibiting the formation of AGEs at the tested concentrations. The cell viability remained above 95% at concentrations up to 800 µg/mL. In conclusion, EHAC has significant therapeutic potential, and further research is warranted for its development as a phytotherapeu-tic, with the aim of preserving the biodiversity of the Brazilian Cerrado.